Healthcare Triangle, Inc. (Nasdaq: HCTI), a prominent provider of digital transformation solutions for the healthcare and life sciences sectors, has announced a 1-for-249 reverse stock split of its common stock. This strategic decision, effective from August 1, 2025, aims to elevate the company's share price to meet the Nasdaq Capital Market's minimum bid price requirement of $1.00, ensuring continued listing and trading under the symbol 'HCTI'.
The reverse stock split, approved by stockholders on February 26, 2025, will convert every 249 shares of issued and outstanding common stock into one share, significantly reducing the total number of outstanding shares from approximately 1.45 billion to about 5.83 million. This adjustment is designed to enhance the stock's marketability and appeal to a broader range of investors, potentially leading to increased liquidity and stability in the company's stock price.
Stockholders will receive detailed information about their adjusted share holdings from VStock Transfer, LLC, the company's transfer agent. The reverse stock split underscores Healthcare Triangle's commitment to maintaining its Nasdaq listing, a critical factor in preserving investor confidence and access to capital markets. Further details are available in the company's definitive information statement filed with the SEC on March 17, 2025.
This move is particularly significant for investors and the healthcare technology industry, as it reflects the company's proactive measures to address compliance challenges and sustain its growth trajectory in a competitive and rapidly evolving sector. The reverse stock split represents a pivotal step in Healthcare Triangle's strategy to reinforce its market position and continue delivering innovative solutions to the healthcare and life sciences industries.
